143 related articles for article (PubMed ID: 17326221)
1. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Schiff E; Lai CL; Hadziyannis S; Neuhaus P; Terrault N; Colombo M; Tillmann H; Samuel D; Zeuzem S; Villeneuve JP; Arterburn S; Borroto-Esoda K; Brosgart C; Chuck S;
Liver Transpl; 2007 Mar; 13(3):349-60. PubMed ID: 17326221
[TBL] [Abstract][Full Text] [Related]
2. Current antiviral therapy for chronic hepatitis B.
Lim YS; Suh DJ
J Korean Med Sci; 2004 Aug; 19(4):489-94. PubMed ID: 15308835
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
Loomba R; Rowley AK; Wesley R; Smith KG; Liang TJ; Pucino F; Csako G
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):696-700. PubMed ID: 18456569
[TBL] [Abstract][Full Text] [Related]
4. Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type 1. The Pediatrics AIDS Clinical Trials Group.
Hughes WT; Shenep JL; Rodman JH; Fridland A; Willoughby R; Blanchard S; Purdue L; Coakley DF; Cundy KC; Culnane M; Zimmer B; Burchett S; Read JS
Antimicrob Agents Chemother; 2000 Apr; 44(4):1041-6. PubMed ID: 10722509
[TBL] [Abstract][Full Text] [Related]
5. Advances in immunomodulating therapy of HBV infection.
Hui CK; Lau GK
Int J Med Sci; 2005; 2(1):24-29. PubMed ID: 15968336
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine Therapy Exacerbates Bilirubinemia in Patients Underlying Severely Advanced Hepatitis.
Choi YH; Lee CH; Ko MS; Han HJ; Kim SG
Toxicol Res; 2017 Oct; 33(4):343-350. PubMed ID: 29071019
[TBL] [Abstract][Full Text] [Related]
7. The BIG question: Can we stop the use of HBIG?
Lee R; Alukal JJ; Gish RG
Liver Transpl; 2024 Jun; 30(6):570-572. PubMed ID: 38289265
[No Abstract] [Full Text] [Related]
8. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
Chang TT; Lai CL; Kew Yoon S; Lee SS; Coelho HS; Carrilho FJ; Poordad F; Halota W; Horsmans Y; Tsai N; Zhang H; Tenney DJ; Tamez R; Iloeje U
Hepatology; 2010 Feb; 51(2):422-30. PubMed ID: 20049753
[TBL] [Abstract][Full Text] [Related]
9. Managing HBV and HCV Infection Pre- and Post-liver Transplant.
Kumar N; Choudhary NS
J Clin Exp Hepatol; 2024; 14(2):101287. PubMed ID: 38076445
[TBL] [Abstract][Full Text] [Related]
10. Current perspective in metal oxide based photocatalysts for virus disinfection: A review.
Soni V; Khosla A; Singh P; Nguyen VH; Le QV; Selvasembian R; Hussain CM; Thakur S; Raizada P
J Environ Manage; 2022 Apr; 308():114617. PubMed ID: 35121465
[TBL] [Abstract][Full Text] [Related]
11. An Overview of the Current Hepatitis B Treatment Strategies after Liver Transplantation.
Dooghaie Moghadam A; Eslami P; Dowlati Beirami A; Iravani S; Farokhi E; Mansour-Ghanaei A; Hashemi MR; Aghajanpoor Pasha M; Mehrvar A; Nassiri-Toosi M
Middle East J Dig Dis; 2021 Jan; 13(1):5-14. PubMed ID: 34712432
[TBL] [Abstract][Full Text] [Related]
12. Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.
Abaalkhail FA; Al Sebayel MI; Shagrani MA; O'Hali WA; Almasri NM; Alalwan AA; Alghamdi MY; Al-Bahili H; AlQahtani MS; Alabbad SI; Al-Hamoudi WK; Alqahtani SA
Saudi Med J; 2021 Sep; 42(9):927-968. PubMed ID: 34470833
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta-analysis.
Lai Q; Mennini G; Giovanardi F; Rossi M; Giannini EG
Eur J Clin Invest; 2021 Aug; 51(8):e13575. PubMed ID: 33866547
[TBL] [Abstract][Full Text] [Related]
14. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges.
Zhao H; Wang Q; Luo C; Liu L; Xie W
Biomed Res Int; 2020; 2020():9609731. PubMed ID: 33029534
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Perrillo RP
Clin Liver Dis (Hoboken); 2013 Nov; 2(Suppl 5):78-82. PubMed ID: 31333830
[No Abstract] [Full Text] [Related]
16. Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination.
Liu Y; Liu H; Hu Z; Ding Y; Pan XB; Zou J; Xi J; Yu G; Huang H; Luo MT; Guo F; Liu S; Sheng Q; Jia J; Zheng YT; Wang J; Chen X; Guo JT; Wei L; Lu F
Hepatology; 2020 Feb; 71(2):463-476. PubMed ID: 31278760
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus: Prevention of recurrent infection.
Villamil FG; Cairo FM
Clin Liver Dis (Hoboken); 2013 Aug; 2(4):169-172. PubMed ID: 30992855
[No Abstract] [Full Text] [Related]
18. Hepatitis B virus treatment: Which patients require immediate treatment.
Perrillo RP
Clin Liver Dis (Hoboken); 2013 Feb; 2(1):11-14. PubMed ID: 30992812
[No Abstract] [Full Text] [Related]
19. Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis.
Siyahian A; Malik SU; Mushtaq A; Howe CL; Majeed A; Zangeneh T; Iftikhar S; Habib S; Zahid U; Riaz IB; Warraich Z; Faridi W; Anwer F
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1483-1489. PubMed ID: 29545185
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
